Novel bretylium compositions and kits and their use in preventing and treating cardiovascular conditions
申请人:——
公开号:US20030119794A1
公开(公告)日:2003-06-26
The present invention is directed to novel pharmaceutical combinations including compositions and kits comprising bretylium as the active ingredient, as well as methods for preventing and/or treating conditions related to the cardiovascular system using such novel pharmaceutical combinations.
本发明涉及包括布雷替琳作为活性成分的新型药物组合物和套装,以及利用这种新型药物组合物预防和/或治疗与心血管系统相关的疾病的方法。